Reply to the Letter by S. Sorscher Regarding "Implications of BRAF Mutations in dMMR Colorectal Cancers"

Curr Treat Options Oncol. 2017 Sep 18;18(10):63. doi: 10.1007/s11864-017-0505-x.

Authors

R Cohen¹, T André²

Affiliations

¹ Department of medical oncology, Hôpital Saint-Antoine, AP-HP, 184 rue du Faubourg Saint-Antoine, 75012, Paris, France.
² Department of medical oncology, Hôpital Saint-Antoine, AP-HP, 184 rue du Faubourg Saint-Antoine, 75012, Paris, France. thierry.andre@aphp.fr.

PMID: 28921484
DOI: 10.1007/s11864-017-0505-x

No abstract available

Keywords: ᅟ.

Publication types

Letter

MeSH terms

Colorectal Neoplasms / drug therapy
Colorectal Neoplasms / genetics*
DNA Mismatch Repair*
Humans
Molecular Targeted Therapy
Mutation*
Proto-Oncogene Proteins B-raf / genetics*

Substances

BRAF protein, human
Proto-Oncogene Proteins B-raf